Ivantis
ClosedIrvine, United States · Founded 2007
- Headquarters
- Irvine
- Founded
- 2007
- Business Model
- B2B
- Website
- ivantisinc.com
- Last Round
- Series BJan 2017
- Rounds
- 3
About
Ivantis was a medical device company developing the Hydrus Microstent, a minimally invasive glaucoma surgery (MIGS) device designed to lower intraocular pressure in patients with primary open-angle glaucoma. The company's device received FDA clearance and was subsequently acquired by Alcon in January 2022 for $475 million.
Summary
Ivantis is a Healthcare company based in Irvine, United States, founded in 2007. Its most recent funding was a Series B round in Jan 2017. Investors include New Enterprise Associates, Foresite Capital and RA Capital Management.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2021
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
operates in the healthcare industry focusing on biotechnology business
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...